Novartis Triaminic Softchews
This article was originally published in The Tan Sheet
Executive Summary
Cherry-flavor Cough & Cold formula, grape Throat Pain & Cough and orange Cold & Allergy tablets begin test market west of the Rockies July 27. Softchews employ Eden Prairie, Minn.-based Cima Labs' proprietary OraSolv fast-dissolve technology pursuant to a June licensing and supply agreement. Novartis plans to begin TV and print ads in the test markets in November. Prices will be in line with liquid formulations of the pediatric cough/cold brand...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning